| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/11/2002 | US20020091132 Composition and method comprising CPT-11 and a pyrimidine derivative for the treatment of cancer |
| 07/11/2002 | US20020091128 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 07/11/2002 | US20020091127 Semicarbazides and their uses |
| 07/11/2002 | US20020091110 Dietary compositions |
| 07/11/2002 | US20020091108 Stable salts of O-acetylsalicylic acid with basic amino acids |
| 07/11/2002 | US20020091107 Treatment of psoriasis, arthritis, and toxicity due to chemotherapy. |
| 07/11/2002 | US20020091104 Protein tyrosine phosphatases inhibitors, especially as antidiabetic agents |
| 07/11/2002 | US20020091100 Also cromolyn salts or esters; may be in combination with a corticosteroid; may also contain an antiphlogistic compound and hyaluronic acid |
| 07/11/2002 | US20020091095 Modulation of Fas and FasL expression |
| 07/11/2002 | US20020091092 Use of propionyl L-carnitine for the preparation of a medicament capable of inducing apoptosis |
| 07/11/2002 | US20020091088 Administration of at least one agent at a level which enhances NO and which does not appreciably alter normal systemic vascular tone |
| 07/11/2002 | US20020091086 Peptides that block viral infectivity and methods of use thereof |
| 07/11/2002 | US20020091084 Human calcineurin B-like protein (CAB) and polynucleotides which identify and encode CAB. |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |
| 07/11/2002 | US20020091075 Administering a kappa opioid receptor antagonist |
| 07/11/2002 | US20020090732 Modulator for use in the treatment of brain, psychological and nervous system disorders |
| 07/11/2002 | US20020090703 Mammalian protein phosphatases |
| 07/11/2002 | US20020090693 Novel human sodium-dependent phosphate cotransporter |
| 07/11/2002 | US20020090636 Screening nucleotide sequences samples; obtain nucleotide sequences, incubate with primers, amplify nucleotide sequences, analyzing amplified nucleotide sequences |
| 07/11/2002 | US20020090624 Gene markers useful for detecting skin damage in response to ultraviolet radiation |
| 07/11/2002 | US20020090622 Detection of a polymorphism in a sodium transport protein; obtain sample, recover nucleotide sequences from sample, determine nucleotide sequences of sample, compare to control |
| 07/11/2002 | US20020090610 Polypeptide for use in the detection, diagnosis, prevention and treatment of vial disease |
| 07/11/2002 | US20020090441 Phytopharmaceutical food products or integrators |
| 07/11/2002 | US20020090403 Antidepressant |
| 07/11/2002 | US20020090401 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia |
| 07/11/2002 | US20020090398 Flowable, biocompatible, branched thermoplastic polymer used to form solid matrices such as implants and controlled-release, drug-formulations in a body |
| 07/11/2002 | US20020090388 Implantable, for sustained delivery of a drug directly into systemic circulation of an animal |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090353 Locally administering to the tumor an antigen-releasing agent, locally administering to tumor leukocyte attractant and tumor interferon-gamma (IFN-g) and a second type 1 inflammatory response-(IR1-)promoting agent for therapy of tumor |
| 07/11/2002 | US20020090352 Compositions and methods for use in modulating immune system function |
| 07/11/2002 | US20020090344 Administering a dose of a mixture of lipid crystals, as an aerosol; propellants are evaporated as aerosolized mixture of lipid crystals come into contact with, and deposits upon the epithelial lining of the upper respiratory system |
| 07/11/2002 | DE10100462A1 Cartridges for preparing dialysis fluids comprises all the ingredients required for an acetate dialysis fluid or a bicarbonate hemodialysis fluid, other than sodium bicarbonate, in the form of a suspension |
| 07/11/2002 | DE10063885A1 Drug formulation useful e.g. for treating angina or hypertension contains thieno (2,3-d) pyrimidine derivative phosphodiesterase V inhibitor and antithrombotic agent, calcium antagonist or prostaglandin, |
| 07/11/2002 | DE10063882A1 Drug formulation useful e.g. for treating angina or hypertension contains pyrazolo (4,3-d) pyrimidine derivative phosphodiesterase V inhibitor and antithrombotic agent, calcium antagonist or prostaglandin |
| 07/11/2002 | CA2689741A1 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2433800A1 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | CA2433781A1 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis |
| 07/11/2002 | CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | CA2433552A1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | CA2433446A1 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | CA2433346A1 Method for treating glaucoma ib |
| 07/11/2002 | CA2433332A1 Agents and methods for treating pain |
| 07/11/2002 | CA2433236A1 Assay to determine efficacy of treatment for m. tuberculosis infection |
| 07/11/2002 | CA2433041A1 Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty |
| 07/11/2002 | CA2432902A1 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | CA2432853A1 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | CA2432504A1 Methods and compositions for treating periodontal disease |
| 07/11/2002 | CA2432184A1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 07/11/2002 | CA2431413A1 Stable skin conditioning compositions containing retinoid boosters |
| 07/11/2002 | CA2431041A1 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/11/2002 | CA2430667A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/10/2002 | EP1221615A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/10/2002 | EP1221326A2 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/10/2002 | EP1221316A1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 07/10/2002 | EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220921A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 07/10/2002 | EP1220917A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 07/10/2002 | EP1220915A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 07/10/2002 | EP1220911A2 P-glycoproteins and uses thereof |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220902A2 Conjugates between a peptide and a nucleic acid analog, such as a pna, lna or a morpholino |
| 07/10/2002 | EP1220869A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 07/10/2002 | EP1220842A1 Cyclic amine compounds as ccr5 antagonists |
| 07/10/2002 | EP1220830A1 Systems and methods for opening obstructed biological conduits |
| 07/10/2002 | EP1220690A2 Injection vehicle for polymer-based formulations |
| 07/10/2002 | EP1220689A2 Treatment of fatigue, head injury and stroke |
| 07/10/2002 | EP1220685A2 Pharmaceutical compositions of fibrinolytic agent |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1220674A1 Pharmaceutical product suitable for use immunosuppressive therapy |
| 07/10/2002 | EP1220667A2 Treating endometriosis or infertility, or improving fertility |
| 07/10/2002 | EP1220666A2 Methods for modulating the human sexual response |
| 07/10/2002 | EP1220657A1 Liposome encapsulated silver salt compositions |
| 07/10/2002 | EP1220656A2 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 07/10/2002 | EP1220617A1 Fish feed with increased nucleotide content |
| 07/10/2002 | EP1220611A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 07/10/2002 | EP0914158B1 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 07/10/2002 | CN1358197A Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 07/10/2002 | CN1358187A New compounds |
| 07/10/2002 | CN1358181A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358179A Thiazole and oxazole derivatives and their pharmaceutical use |
| 07/10/2002 | CN1358174A New Compounds |
| 07/10/2002 | CN1358099A Utilization of aminopeptidase inhibitor |
| 07/10/2002 | CN1358091A Estrogen receptor-beta ligands |
| 07/10/2002 | CN1358087A Timed dual release dosage forms comprising short acting hypnotic or salt thereof |
| 07/10/2002 | CN1357346A Osteoporosis treaitng medicine comprising effective components extracted from Chinese medicinal material |
| 07/10/2002 | CN1357321A Inflammation and red spot reducing method |
| 07/09/2002 | US6417334 Antagonists to chaperonin 10 |
| 07/09/2002 | US6417329 Purified polypeptide |
| 07/09/2002 | US6417237 Macromolecular drug complexes and compositions containing the same |
| 07/09/2002 | US6417229 Enzyme inhibitors |
| 07/09/2002 | US6417220 A medicine for preventive/treatment of disease caused by mitochondrial membrane depolarization because of elevation of intracellular calcium ion concentration; benzodiazepine receptor antagonist, e.g.,nefiracetam; antiischemic agents |
| 07/09/2002 | US6417209 Heterocyclic ketone and thioester compounds and uses |
| 07/09/2002 | US6417205 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/09/2002 | US6417204 Cardiovascular disoders |
| 07/09/2002 | US6417196 Stabilization of quinapril using magnesium oxide |
| 07/09/2002 | US6417193 Methods for inhibiting MRP1 |
| 07/09/2002 | US6417189 Drugs with pyrazole ketone derivatives |